New report published by Global Info Research which offers insights on the global BCG Vaccine market.
BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme.
Click to view the full report TOC, figure and tables:
https://www.globalinforesearch.com/global-bcg-vaccine-market_p58676.html
Global BCG Vaccine Market: Forecast by Type / Application / Region
Besides, BCG Vaccine is also used to treat a certain type of bladder cancer. Bladder cancer is the growth of abnormal or cancerous cells on the inner lining of the bladder wall. BCG helps prevent the cancer from coming back in the bladder lining, and also reduces the risk of it becoming invasive.
Global BCG Vaccine market include: Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, Serum Institute of India, Intervax and GSBPL.
On the basis of product, the BCG Vaccine market is primarily split into: Immune BCG and Therapy BCG.
On the basis on the end users/applications, this report covers: Hospital and Clinic.
In the last several years, Global market of BCG Vaccine developed rapidly, with an average growth rate of 5.64%. In 2017, Global revenue of BCG Vaccine is about 300 M USD.
The global average price of BCG Vaccine is in the decreasing trend, from 3.42 USD/mg in 2013 to 3.26 USD/mg in 2017. With the situation of global economy, prices will be in decreasing trend in the following five years.
The type of BCG Vaccine includes Immune BCG and Therapy BCG. The proportion of Therapy BCG in 2017 is about 92%.
BCG Vaccine is widely used in Hospitals and Clinics. The most proportion of BCG Vaccine is sold in Hospitals and the market share in 2017 is about 74%, and the Hospitals have upstream trend.
Japan is the largest supplier of BCG Vaccine, with a production market share nearly 31% in 2017. North America is the second largest supplier of BCG Vaccine Media, enjoying production market share nearly 26% in 2017.
Ask for Discount on Research Report and Request Sample Copy of Report@
https://www.globalinforesearch.com/global-bcg-vaccine-market_p58676.html
About Us:
GlobalInfoResearch is a report publisher, a customer, interest-based suppliers. Is in the best interests of our clients, they determine our every move. At the same time, we have great respect for the views of customers. With the improvement of the quality of our research, we develop custom interdisciplinary and comprehensive solution. For further development, we will do better and better. GlobalInfoResearch will with excellent professional knowledge and experience to carry out all aspects of our business. At the same time, we will thoroughly look for information, to give a more comprehensive development.
Related Information:
United States BCG Vaccine Market 2018 Forecast to 2023
Europe BCG Vaccine Market 2018 Forecast to 2023
North America BCG Vaccine Market 2018 Forecast to 2023
Asia-Pacific BCG Vaccine Market 2018 Forecast to 2023
China BCG Vaccine Market 2018 Forecast to 2023
EMEA BCG Vaccine Market 2018 Forecast to 2023
Global BCG Vaccine Market 2018 Forecast to 2023
Contact US :
JOE
Sales Director (Global Info Research)
E-mail: report@globalinforesearch.com
Tel: +86-15521064060 00852-58197708(HK)
Add: RM 1605C HO KING COMM CTR 2-16 FA YUEN ST MONGKOK KL Hong Kong
Website: http://www.globalinforesearch.com
